insights_auto
Zašto je ALMKT pao 2,79%?
Istražite detaljnijechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,087 €
arrow_downward
−2,79%(−0,0025) 1D
20. stu, 17:35:11 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALMKT...
Otvori
0,09 €
Najviša
0,09 €
Najniža
0,09 €
Trž. kap.
16,66 mil.
Prosj. kol.
406,96 tis.
Količina
258,62 tis.
P/E omjer
0,74
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Otvori
0,09 €
Najviša
0,09 €
Najniža
0,09 €
Trž. kap.
16,66 mil.
Prosj. kol.
406,96 tis.
Količina
258,62 tis.
P/E omjer
0,74
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Vijesti
Iz web-izvora i od partnera za vijesti
AP News
·
prije 12 sati
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
prije 3 sata
25 S&P 500 Stocks Just Made New 52-Week Lows
Yahoo Finance
·
prije 15 sati
Wall St ends sharply lower on AI selloff, S&P 500, Dow in correction
ABC News - Breaking News, Latest News and Videos
·
prije 1 dan
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year as rout in tech stocks tanks the market
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA – informacije
Glavni izvršni direktorSacha Loiseau
Zaposlenici56
Osnovano2000
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijamaunakeatech.com